These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30365097)

  • 1. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
    Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X
    Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
    Zhang S; Zhang X; Fu X; Li W; Xing S; Yang Y
    Oncol Lett; 2018 Aug; 16(2):2391-2401. PubMed ID: 30013629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer.
    Feng Y; Hang W; Sang Z; Li S; Xu W; Miao Y; Xi X; Huang Q
    Mol Med Rep; 2019 May; 19(5):3376-3392. PubMed ID: 30864705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
    Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders.
    Yang Z; Wei Z; Wu X; Yang H
    Mol Med Rep; 2018 Sep; 18(3):3314-3324. PubMed ID: 30066923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
    Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
    EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression Profiles Identify Biomarker for Differentiating the Embolic Stroke from Thrombotic Stroke.
    Chen LT; Jiang CY
    Biomed Res Int; 2018; 2018():4514178. PubMed ID: 30627556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
    Peng Y; Song X; Lan J; Wang X; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
    Chang WS; Wang YH; Zhu XT; Wu CJ
    Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identfication of key miRNAs in pancreatitis using bioinformatics analysis of microarray data.
    Wang D; Zhu ZM; Tu YL; Dou CQ; Xu Y; Tan XL; Han MM; Yang ZJ; Jin X; Zhang B; Cai S; Liu ZW
    Mol Med Rep; 2016 Dec; 14(6):5451-5460. PubMed ID: 27840954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.
    Li Y; Wang Q; Ning N; Tang F; Wang Y
    J Ovarian Res; 2020 Jul; 13(1):77. PubMed ID: 32660514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.